U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 01:15:24 GMT 2025
Edited
by admin
on Wed Apr 02 01:15:24 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
G86X5QQ7M5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EMB-01
Preferred Name English
Bafisontamab
INN   USAN  
Official Name English
BAFISONTAMAB [USAN]
Common Name English
Bafisontamab [WHO-DD]
Common Name English
Immunoglobulin G1, bispecific, anti-(human hepatocyte growth factor receptor c-Met) (human ?-chain) fusion protein with immunoglobulin G1 anti-(human epidermal growth factor receptor) (human ?1-chain), disulfide with immunoglobulin G1 anti-(human hepatoc
Common Name English
EMB01
Common Name English
FIT-013A
Common Name English
ANTI-EGFR/ANTI-C-MET BISPECIFIC ANTIBODY EMB-01
Common Name English
bafisontamab [INN]
Common Name English
Immunoglobulin G1-kappa-Fab, anti-[Homo sapiens MET (MET proto-oncogene receptor tyrosine kinase, HGFR, RCCP2, DFNB97)] and anti-[Homo sapiens EGFR (epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-1, ERBB1, HER1, HER-1, ERBB)], Ho
Common Name English
Code System Code Type Description
NCI_THESAURUS
C158085
Created by admin on Wed Apr 02 01:15:25 GMT 2025 , Edited by admin on Wed Apr 02 01:15:25 GMT 2025
PRIMARY NCIT
FDA UNII
G86X5QQ7M5
Created by admin on Wed Apr 02 01:15:25 GMT 2025 , Edited by admin on Wed Apr 02 01:15:25 GMT 2025
PRIMARY
INN
11851
Created by admin on Wed Apr 02 01:15:25 GMT 2025 , Edited by admin on Wed Apr 02 01:15:25 GMT 2025
PRIMARY
SMS_ID
300000039131
Created by admin on Wed Apr 02 01:15:25 GMT 2025 , Edited by admin on Wed Apr 02 01:15:25 GMT 2025
PRIMARY
USAN
LM-244
Created by admin on Wed Apr 02 01:15:25 GMT 2025 , Edited by admin on Wed Apr 02 01:15:25 GMT 2025
PRIMARY
CAS
2437210-79-0
Created by admin on Wed Apr 02 01:15:25 GMT 2025 , Edited by admin on Wed Apr 02 01:15:25 GMT 2025
PRIMARY
From To
1_23 1_88
1_134 1_194
1_214 3_220
1_236 1_311
1_360 1_416
1_436 5_214
1_442 2_442
1_445 2_445
1_477 1_537
1_583 1_641
2_23 2_88
2_134 2_194
2_214 4_220
2_236 2_311
2_360 2_416
2_436 6_214
2_477 2_537
2_583 2_641
3_22 3_96
3_144 3_200
4_22 4_96
4_144 4_200
5_23 5_88
5_134 5_194
6_134 6_194
6_23 6_88
6_23 6_88
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_513
N 2_513
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID REMOVAL [1_663] [2_663] C-TERMINUS LYSINE K3Z4F929H6
AMINO_ACID_SUBSTITUTION [3_1] [4_1] N-TERMINUS PIDOLIC ACID SZB83O1W42
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL